Skip to main content
TipRanks
Go Ultimate75% OFF

ME Therapeutics Holdings, Inc. (METX) Stock Statistics & Valuation Metrics

10 Followers

Total Valuation

ME Therapeutics Holdings, Inc. has a market cap or net worth of CAD 31.55M. The enterprise value is CAD 51.18M.

Market Cap
CAD 31.55M
Enterprise Value
CAD 51.18M

Share Statistics

ME Therapeutics Holdings, Inc. has 30,049,494 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
30,049,494
Owned by Insiders
16.21%
Owned by Institutions
―

Financial Efficiency

ME Therapeutics Holdings, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, ME Therapeutics Holdings, Inc. had revenue of ― and earned -57.46K in profits. Earnings per share was ―.

Revenue
―
Gross Profit
―
Operating Income
-60.28K
Pretax Income
―
Net Income
-57.46K
EBITDA
-57.46K
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
1.19
52-Week Price Change
-73.75%
50-Day Moving Average
1.94
200-Day Moving Average
2.29
Relative Strength Index (RSI)
37.84
Average Volume (3m)
4,724

Important Dates

ME Therapeutics Holdings, Inc. upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).

Last Earnings Date
Jun 26, 2026
Next Earnings Date
Dec 02, 2026
Ex-Dividend Date
―

Balance Sheet

ME Therapeutics Holdings, Inc. has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 0.00
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for ME Therapeutics Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
-5.48%